Ms. Alison Mary Coutts B.E., M.B.A., B.E. (Chem), GDipBiotech, MBA
Director of Fin.:
Chief Financial Officer of Nusep Ltd:
Mr. Malcolm Coleman
Mr. Andrew Metcalfe
Memphasys Limited, a bio-separations company, develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that uses high quality sperm cells from semen samples for human assisted reproductive technologies for treating male factor infertility; hydrogels; and other polymer membranes to separate cells from fluids. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited was incorporated in 2006 and is headquartered in Homebush, Australia.